APRE icon

Aprea Therapeutics
APRE

Overview Fund Activity

24 hedge funds and large institutions have $521K invested in Aprea Therapeutics in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 5 closing their positions.

Holders
24
Holders Change
-2
Holders Change %
-7.69%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
7
Reduced
7
Closed
5
Calls
$186K
Puts
$4K
Net Calls
+$182K
Net Calls Change
-$195K

Top Buyers

1
Jane Street
1
Jane Street
New York
$16.9K
2
Millennium Management
2
Millennium Management
New York
$53K
3
TRCT
3
Tower Research Capital (TRC)
New York
$15K
4
UBS Group
4
UBS Group
Switzerland
$8.49K
5
Group One Trading
5
Group One Trading
Illinois
$14.2K

Top Sellers

1
BNP Paribas Financial Markets
1
BNP Paribas Financial Markets
France
$0
2
Renaissance Technologies
2
Renaissance Technologies
New York
$59K
3
Verition Fund Management
3
Verition Fund Management
Connecticut
$0
4
BCM
4
Bridgeway Capital Management
Texas
$0
5
Morgan Stanley
5
Morgan Stanley
New York
$91.3K
Name Holding Trade Value Shares
Change 		Shares
Change %
Verition Fund Management
26
Verition Fund Management
Connecticut
– -$13K -1,005 Closed
BCM
27
Bridgeway Capital Management
Texas
– -$13K -1,000 Closed
Two Sigma Investments
28
Two Sigma Investments
New York
– -$11K -842 Closed
SG
29
StoneX Group
New York
– -$8.14K -626 Closed
1
2